Is Avricore Health Inc. (AVCR.V) a Buy, Sell, or Hold?
TSXV : AVCR.V
Avricore Health Inc.
$0.06 CAD
$0 (0.0%)
- Volume
- 5K
- Average Volume
- 28.2K
- Market Capitalization
- $6.08M
- P/E Ratio
- -3.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.05
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.03
Industry, Sector & symbol
| Stock Exchange | TSXV |
| CEO | Rodger Seccombe |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | AVCR.V |
| CUSIP | 054521109 |
| CIK | None |
| Web | https://www.avricore.com |
| Phone | 604-773-8943 |
| Currency | CAD |
| Employees | 26 |
| Country | CA |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.03 |
| Quick Ratio | 0.93 |
| Cash Ratio | 0.51 |
Sales & Book Value
| Annual Sales | $533.88K |
| Price / Sales | 42.16 |
| Cash Flow | -0.01 |
| Price / Cash Flow | -5.72 |
| Price / Book | 31.13 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$0.0184 |
| Trailing P/E Ratio | -3.08 |
| PEG Ratio | 0.05 |
| P/E Growth | 0.05 |
| Net Income | -$1.86M |
| Net Margin | -1378.04% |
| Pretax Margin | -1378.04% |
| Return on Equity | -227.06% |
| Return on Assets | -339.90% |
Financials Score
| AltmanZ Score | -81.62 |
| Piotroski Score | 1.00 |
| Working Capital | 11.57K |
| Total Assets | 584.37K |
| Ebit | -1.54M |
| Market Cap | 6.08M |
| Total Liabilities | 389.17K |
Poll Results
About Avricore Health Inc. (TSXV:AVCR.V) Stock
Avricore Health Inc. operates within Canada, specializing in health data management and point-of-care technological solutions. Their primary offering is HealthTab, a precise, laboratory-quality diagnostic testing system designed for use in pharmacies. This enterprise maintains key alliances with prominent organizations such as Shoppers Drug Marts and Abbott. Established in 1996 and headquartered in Vancouver, Canada, the company previously operated as Vanc Pharmaceuticals Inc., adopting its current name, Avricore Health Inc., in October 2018. ...
Frequently Asked Questions
-
What is the current Avricore Health Inc. (AVCR.V) stock price?
-
Avricore Health Inc.(TSXV:AVCR.V) stock price is $0.06 in the last trading session. During the trading session, AVCR.V stock reached the peak price of $0.1 while $0.045 was the lowest point it dropped to. The percentage change in AVCR.V stock occurred in the recent session was 0.0% while the dollar amount for the price change in AVCR.V stock was $0.
-
AVCR.V's industry and sector of operation?
-
The TSXV listed AVCR.V is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of AVCR.V?
-
Kiriaki Smith | Chief Financial Officer & Corporate Secretary
Rodger Seccombe | Chief Executive Officer, Chief Technology Officer & Director
Will Seccombe | Communications Advisor
|
| -
How many employees does AVCR.V have?
-
Number of AVCR.V employees currently stands at 26. AVCR.V operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.
-
Link for AVCR.V official website?
-
Official Website of AVCR.V is: https://www.avricore.com
-
How do I contact AVCR.V?
-
AVCR.V could be contacted at phone #604-773-8943 and can also be accessed through its website. AVCR.V operates from 789 West Pender Street, Vancouver, BC V6C 1H2, CA.
-
How many shares of AVCR.V are traded daily?
-
The average number of AVCR.V shares traded daily for last 3 months was 28.2K.
-
What is the market cap of AVCR.V currently?
-
The market value of AVCR.V currently stands at $6.08M with its latest stock price at $0.06